Arnold Library

Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.

Morgan, Todd M and Welty, Christopher J and Vakar-Lopez, Funda and Lin, Daniel W and Wright, Jonathan L (2010) Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. The Journal of urology, 184 (6). pp. 2303-2307. ISSN 1527-3792

[img] Text (Accepted manuscript)
WrightJL_JUrology_050611FullManuscript.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (220Kb)
Article URL: http://www.sciencedirect.com/science/article/pii/S...

Abstract

The clinical significance of ductal prostatic carcinoma is not well-defined. In a population based cancer registry we identified a large group of patients with ductal carcinoma to characterize the impact of the ductal subtype on presentation and survival in men with prostate cancer.

Item Type: Article
Additional Information: This article is freely available in PubMed Central.
DOI: 10.1016/j.juro.2010.08.017
PubMed ID: 20952027
NIHMSID: NIHMS294511
PMCID: PMC3111052
Grant Numbers: T32 CA009168
Keywords or MeSH Headings: Adenocarcinoma/blood/mortality/pathology; Aged; Humans; Male; Middle Aged; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood/mortality/pathology; Risk Factors;
Depositing User: Library Staff
Date Deposited: 09 May 2012 22:51
Last Modified: 09 May 2012 22:51
URI: http://authors.fhcrc.org/id/eprint/487

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy